ATE375170T1 - Adjuvanskombinationen zur immunisierung und vakzine - Google Patents

Adjuvanskombinationen zur immunisierung und vakzine

Info

Publication number
ATE375170T1
ATE375170T1 AT00926717T AT00926717T ATE375170T1 AT E375170 T1 ATE375170 T1 AT E375170T1 AT 00926717 T AT00926717 T AT 00926717T AT 00926717 T AT00926717 T AT 00926717T AT E375170 T1 ATE375170 T1 AT E375170T1
Authority
AT
Austria
Prior art keywords
vaccines
immunization
adjuvant
relates
adjuvant combinations
Prior art date
Application number
AT00926717T
Other languages
English (en)
Inventor
Erik Lindblad
Martin Elhay
Peter Andersen
Lise Brandt
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of ATE375170T1 publication Critical patent/ATE375170T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00926717T 1999-05-12 2000-05-12 Adjuvanskombinationen zur immunisierung und vakzine ATE375170T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199900655 1999-05-12

Publications (1)

Publication Number Publication Date
ATE375170T1 true ATE375170T1 (de) 2007-10-15

Family

ID=8096034

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00926717T ATE375170T1 (de) 1999-05-12 2000-05-12 Adjuvanskombinationen zur immunisierung und vakzine

Country Status (7)

Country Link
EP (1) EP1183044B1 (de)
AT (1) ATE375170T1 (de)
AU (1) AU4537100A (de)
DE (1) DE60036705T2 (de)
DK (1) DK1183044T3 (de)
ES (1) ES2293898T3 (de)
WO (1) WO2000069458A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806913B1 (fr) * 2000-03-31 2003-01-31 Pf Medicament Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosale
KR100992646B1 (ko) * 2003-07-09 2010-11-05 제이에스알 가부시끼가이샤 파장판
ES2784189T3 (es) 2009-03-27 2020-09-23 Academia Sinica Métodos y composiciones para la inmunización contra virus
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5951988A (en) * 1993-03-30 1999-09-14 University Of Saskatchewan Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DE4333376C2 (de) * 1993-09-30 1995-09-07 Gerbu Biotechnik Gmbh Mittel zur Steigerung der Ausbeute von Antikörpern in der Immunologie
DE19611235C1 (de) * 1996-03-21 1997-06-05 Gerbu Biotechnik Gmbh Mittel zur Steigerung der Ausbeute von Antikörpern in der Immunologie 2

Also Published As

Publication number Publication date
DE60036705T2 (de) 2008-07-24
ES2293898T3 (es) 2008-04-01
WO2000069458A3 (en) 2001-03-08
DK1183044T3 (da) 2007-12-27
DE60036705D1 (de) 2007-11-22
WO2000069458A2 (en) 2000-11-23
EP1183044B1 (de) 2007-10-10
EP1183044A2 (de) 2002-03-06
AU4537100A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
CY2017009I1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DE60335010D1 (de) Immunstimulatorische zusammensetzungen und verfahren zur stimulierung einer immunantwort
DE602004020189D1 (de) Adjuvante influenza-vakzine
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
NO20063254L (no) Immunstimulerende sammensetning omfattende minst en toll-lignende reseptor 7 eller toll-lignende reseptor 8 agonist og en toll-lignende reseptor 4 agonist
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
MY133780A (en) Vaccine composition
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
WO1999041368A3 (en) Optimization of immunomodulatory properties of genetic vaccines
NO991524L (no) Vaksiner
CY1112862T1 (el) Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα
DE69431358D1 (de) Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien
MXPA04001224A (es) Agentes para incrementar la respuesta inmune.
ES2346314T3 (es) Antigenos de b. pertussis y uso de los mismos en vacunacion.
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
BR0306905A (pt) Vacinas de flavivìrus
CY1107451T1 (el) Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
ATE511855T1 (de) Adjuvansformulierung zur scheimhaut-applikation
DE69738271D1 (de) Rotavirus-impfstoff
DE60042816D1 (de) T-helferzellen-epitope
CY1110718T1 (el) Ανοσογονες λιποσωμικες συνθεσεις
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
ATE375170T1 (de) Adjuvanskombinationen zur immunisierung und vakzine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties